News
University Hospitals Cleveland Medical Center Leverages TriNetX to Assess Study Feasibility & Foster Research Collaborations
Cambridge, MA, January 7, 2019 — University Hospitals (UH) Cleveland Medical Center, a 1,032-bed, tertiary medical centerin Northern Ohio, has joined the TriNetX global health research network. “Our interest in joining TriNetX is threefold,” said Grace A. McComsey,...
TriNetX Real-World Evidence Platform Validates Outcomes of Randomized Clinical Trials
New Cardiovascular Study Affirms Advantages of an Antidiabetic Treatment Class When Treating Patients with Diabetes
World Journal of Diabetes – “Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes”
This study published in the World Journal of Diabetes evaluates the effect on cardiovascular outcomes of sodium-glucose co-transporter-2 (SGLT2) inhibitors in a real world setting by analyzing electronic medical records.Manfred Paul Stapff, CMO, TriNetX Inc.,...
ISPOR Europe 2018 – Parkinson’s Disease Study
This scientific poster investigates the risk of Parkinson's Disease (PD) in patients taking adrenergic drug treatments. Download the poster >>
ISPOR Europe 2018 – Suicidality Study
This scientific poster is comparing the risk of suicidality in adult versus youth patients treated with serotonin reuptake inhibitors—A real-world evidence-based approach. Download the poster >>